Active Studies
The LUCINDA Trial: Lupron + Cholinesterase Inhibition to Reduce Neurologic Decline in Alzheimer’s Disease
To conduct a randomized double-blind, placebo-controlled trial of Lupron and donepezil in women with mild to moderate Alzheimer’s disease to improve cognition and activities of daily living.